Self evaluation of communication experiences after laryngeal cancer - a longitudinal questionnaire study in patients with laryngeal cancer

Mia Johansson, Anna Rydén, Caterina Finizia, Mia Johansson, Anna Rydén, Caterina Finizia

Abstract

Background: Aim of this longitudinal study was to investigate the sensitivity to change of the Swedish Self Evaluation of Communication Experiences after Laryngeal Cancer questionnaire (the S-SECEL), addressing communication dysfunction in patients treated for laryngeal cancer. Previous studies have highlighted the need for more specific questionnaires for this purpose.

Methods: 100 patients with Tis-T4 laryngeal cancer were included prior to treatment onset. Patients answered four questionnaires at six occasions during one year; the S-SECEL, the European Organisation for Research and Treatment of Cancer (EORTC) Core Quality of Life Core Questionnaire (QLQ-C30) supplemented by the Head and Neck cancer module (QLQ-H&N35) and the Hospital Anxiety and Depression (HAD) scale. In addition, performance status was assessed. Differences within groups were tested with the Wilcoxon paired signed ranks test and between-group analyses were carried out using the Mann-Whitney U test. Magnitude of group differences was analyzed by means of effect sizes.

Results: The S-SECEL was well accepted with a response rate of 76%. Communication dysfunction increased at 1 month, followed by a continuous decrease throughout the year. Changes were statistically significant at most measurement, demonstrating the sensitivity of the S-SECEL to changes in communication over time. The S-SECEL and the EORTC QLQ-C30 with the QLQ-H&N35 demonstrated similar results; however the S-SECEL was more sensitive regarding communication dysfunction. The largest changes were found in the most diagnose specific items concerning voice and speech.

Conclusion: The S-SECEL was investigated in the largest Scandinavian longitudinal study concerning health-related quality of life (HRQL) in laryngeal cancer patients. The questionnaire was responsive to change and showed convergent results when compared to established HRQL questionnaires. Our findings also indicate that the S-SECEL could be a more suitable instrument than the EORTC QLQ-C30 with QLQ-H&N35 when measuring communication experiences in patients with laryngeal cancer; it is more sensitive, shorter and can be used on an individual basis. As a routine screening instrument the S-SECEL could be a valuable tool for identifying patients at risk for psychosocial problems and to help plan rehabilitation. It is therefore recommended for clinical use in evaluation of communication dysfunction for all patients with laryngeal cancer irrespective of treatment.

Figures

Figure 1
Figure 1
Mean S-SECEL total and subscale scores. Shows the mean values over time during the study year for S-SECEL total score and subscales. All patients who answered the questionnaires at each measurement point were included in the figure, while the p-values refer to Wilcoxon signed rank test in patients with both baseline and follow-up assessments. S-SECEL = Swedish Self Evaluation of Communication Experiences after Laryngeal Cancer. env = environmental subscale, gen = general subscale, att = attitudinal subscale, tot = total score.
Figure 2
Figure 2
Changes (effects sizes) in S-SECEL and HAD. Changes (effects sizes) in S-SECEL and HAD between (a) baseline and 1 month follow-up and (b) baseline and 12 month follow-up; neg = negative change, i.e. increased dysfunction and anxiety/depression.

References

    1. Atesci FC, Baltalarli B, Oguzhanoglu NK, Karadag F, Ozdel O, Karagoz N. Psychiatric morbidity among cancer patients and awareness of illness. Support Care Cancer. 2004;12:161–167. doi: 10.1007/s00520-003-0585-y.
    1. Grassi L, Gritti P, Rigatelli M, Gala C. Psychosocial problems secondary to cancer: an Italian multicentre survey of consultation-liaison psychiatry in oncology. Italian Consultation-Liaison Group. Eur J Cancer. 2000;36:579–585. doi: 10.1016/S0959-8049(99)00285-3.
    1. Keller M, Sommerfeldt S, Fischer C, Knight L, Riesbeck M, Lowe B, Herfarth C, Lehnert T. Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach. Ann Oncol. 2004;15:1243–1249. doi: 10.1093/annonc/mdh318.
    1. Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys. 1994;28:847–856.
    1. Bjordal K, Kaasa S. Psychological distress in head and neck cancer patients 7-11 years after curative treatment. Br J Cancer. 1995;71:592–597.
    1. Graeff A, Leeuw R, Ros W, Hordijk GJ, Battermann J, Blijham G, Winnubst J. A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy. Head Neck. 1999;21:291–296. doi: 10.1002/(SICI)1097-0347(199907)21:4<291::AID-HED1>;2-B.
    1. Cella DF, Tulsky DS, Gray G, al The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J-Clin-Oncol. 1993;11:570–579.
    1. List MA, Ritter-Sterr C, Lansky SB. A performance status scale for head and neck cancer patients. Cancer. 1990;66:564–569. doi: 10.1002/1097-0142(19900801)66:3<564::AID-CNCR2820660326>;2-D.
    1. List MA, D'Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, al The Performance Status Scale for head and neck cancer patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. Cancer. 1996;77:2294–2301. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>;2-S.
    1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, al The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376. doi: 10.1093/jnci/85.5.365.
    1. Bjordal K, Elmqvist MA, Tollesson E, Jensen AB, Razavi D, Maher EJ, al. Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol. 1994;33:879–885. doi: 10.3109/02841869409098450.
    1. Coul BMO, Ackerstaff AH, As CJ, Hoogen FJ, Meeuwis CA, Manni JJ, al. Quality of life assessment in laryngectomized individuals: do we need additions to standard questionnaires in specific clinical research projects? Clin Otolaryngol. 2005;30:169–175. doi: 10.1111/j.1365-2273.2004.00932.x.
    1. Müller R, Paneff J, Köllner V, Koch R. Quality of life of patients with laryngeal carcinoma: a post-treatment study. Eur Arch Otorhinolaryngol. 2001;258:276–280.
    1. Blood G. Development and assessment of a scale addressing communication needs of patients with laryngectomies. AJSLP. 1993. pp. 82–87.
    1. Blood GW, Dineen M, Kauffman SM, Raimondi SC, Simpson KC. Perceived control, adjustment, and communication problems in laryngeal cancer survivors. Percept Mot Skills. 1993;77:764–766.
    1. Finizia C, Bergman B, Lindstrom J. A cross-sectional validation study of Self-Evaluation of Communication Experiences after Laryngeal Cancer--a questionnaire for use in the voice rehabilitation of laryngeal cancer patients. Acta Oncol. 1999;38:573–580. doi: 10.1080/028418699431159.
    1. Finizia C, Palmé C, Bergman B. A longitudinal study of the Swedish Self-Evaluation of Communication Experiences after Laryngeal Cancer questionnaire in patients treated for laryngeal cancer. Acta Oncol. 2002;41:262–268. doi: 10.1080/02841860260088809.
    1. Aaronson NK, Bullinger M, Ahmedzai S. A modular approach to quality-of-life assessment in cancer clinical trials. Recent Results in Cancer Research. 1988;111:231–249.
    1. Hammerlid E, Bjordal K, Ahlner-Elmqvist M, Jannert M, Kaasa S, Sullivan M, al. A prospective longitudinal quality of life study of patients with head and neck cancer. Otolaryngol Head Neck Surg. 1997;116:666–673. doi: 10.1016/S0194-5998(97)70246-8.
    1. Bjordal K, Graeff A, Fayers PM, Hammerlid E, Pottelsberghe C, Curran D, al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. Eur J Cancer. 2000;36:1796–1807. doi: 10.1016/S0959-8049(00)00186-6.
    1. Fayers P, Aaronson NK, Bjordal K, Sullivan M. Scoring Manual: EORTC QLQ-C30. Belgium , EORTC Data Center; 1995.
    1. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of- life scores. J Clin Oncol. 1998;16:139–144.
    1. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Bergman B, Sullivan M, Sorenson S. Quality of life during chemotherapy for small cell lung cancer. I. An evaluation with generic health measures. Acta Oncol. 1991;30:947–957. doi: 10.3109/02841869109088248.
    1. Hilgers FJ, Ackerstaff AH, Aaronson NK, Schouwenburg PF, Zandwijk NV. Physical and psychosocial consequences of total laryngectomy. Clin Otolaryngol. 1990;15:421–425. doi: 10.1111/j.1365-2273.1990.tb00494.x.
    1. Chaturvedi SK, Shenoy A, Prasad KM, Senthilnathan SM, Premlatha BS. Concerns, coping and quality of life in head and neck cancer patients. Support Care Cancer. 1996;4:186–190. doi: 10.1007/BF01682338.
    1. Mykletun A, Stordal E, Dahl AA. Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry. 2001;179:540–544. doi: 10.1192/bjp.179.6.540.
    1. Smith AB, Selby PJ, Velikova G, Stark D, Wright EP, Gould A, Cull A. Factor analysis of the Hospital Anxiety and Depression Scale from a large cancer population. Psychol Psychother. 2002;75:165–176. doi: 10.1348/147608302169625.
    1. Sullivan M, Karlsson J, Sjöström L, Backman L, Bengtsson C, Bouchard C, Dahlgren S, Jonsson E, Larsson B, Lindstedt S, Näslund I, Olbe L, Wedel H. Swedish obese subjects (SOS) - an intervention study of obesity. Baseline evaluation of health and psychosocial functioning in the first 1,743 subjects examined. Int J Obes Relat Metab Disord. 1993;17:503–512.
    1. Bradley JW. Distribution-free statistical tests. London , Prentice-Hall; 1968.
    1. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ , Lawrence Earlbaum Press; 1988.
    1. Leeper A, Parsa V, Jamieson DG, Heeneman H. Acoustical aspects of vocal function following radiotherapy for early T1a laryngeal cancer. Journal of Voice. 2002;16:289–302. doi: 10.1016/S0892-1997(02)00100-5.
    1. Hammerlid E, Mercke C, Sullivan M, Westin T. A prospective quality of life study of patients with laryngeal carcinoma by tumor stage and different radiation therapy schedules. Laryngoscope. 1998;108:747–759. doi: 10.1097/00005537-199805000-00023.
    1. Singer S, Danker H, Dietz A, Hornemann B, Koscielny S, Oeken J, Matthaüs C, Vogel HJ, Krau O. Screening for mental disorders in laryngeal cancer patients: a comparison of 6 methods. Psycho-Oncology. 2007;DOI: 10.1002/pon.1229
    1. Walker J, Postma K, McHugh G, Rush R, Coyle B, Strong V, Sharpe M. Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients. J Psychosom Res. 2007;63:83–91. doi: 10.1016/j.jpsychores.2007.01.009.
    1. Zöger S, Svedund J, Holgers KM. The Hospital Anxiety and Depression Scale (HAD) as a screening instrument in tinnitus evaluation. International Journal of Audiology. 2004;43:458–464. doi: 10.1080/14992020400050058.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться